CannabisNewsBreaks

ThursdayDec 02, 2021 12:44 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Embarking on Potentially Pivotal Study to Evaluate DehydraTECH-CBD

Lexaria Bioscience Corp. (NASDAQ: LEXX) has embarked on its most ambitious study yet, the HYPER-H21-4. The study is among several geared towards evaluating DehydraTECH(TM)-processed CBD for the potential treatment of hypertension and heart disease. The learnings from two studies, HYPER-H21-1 and HYPER-H21-2, whose results are already out, have led to the HYPER-H21-4 clinical study. Further, blood pressure findings from HYPER-H21-3 will be reportable by the end of January 2022 and will contribute to the HYPER-H21-4. The study protocols for HYPER-H21-4 are being readied for submission to the Independent Review Board (“IRB”), and approval is expected by January 2022. HYPER-H21-4, which…

Continue Reading

ThursdayDec 02, 2021 11:45 am

CannabisNewsBreaks – Simply Sonoma Enters Growing CBD-Infused Beverages Space

Simply Sonoma, a company committed to offering CBD products for the environmentally conscious consumer, is branching out into the beverage space with an alcohol-free, CBD wine product as well as a Pinot Noir/CBD sparkling product. A Facts and Factors report expects that the global CBD-infused beverages market will grow at a CAGR of approximately 27.5% between 2021 and 2026, driven by the rising authorization and certification for recreational cannabis in countries such as the United States and Canada (https://cnw.fm/r7NM8). Furthermore, there is a growing movement away from smoking cannabis and adopting healthier edible options because of the increasing incidence of numerous…

Continue Reading

ThursdayDec 02, 2021 10:32 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Receives Initial Orders from Mexico, Spain

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is expanding internationally. The company’s Flora Beauty division received its first-ever orders for its Mind Naturals and Awe CBD skincare brands for the Spanish and Mexican markets; the company plans to ship the product this month. Flora Beauty’s Mind Naturals brand is designed with young consumers who are just starting a skincare routine while its the AWE brand targets consumers who value customized and personal experiences. The Mind Naturals line was recently named a top-12 finalist in a global pitch competition sponsored by Glosswire. The…

Continue Reading

TuesdayNov 30, 2021 2:08 pm

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Q3 2021 Report Showing 1,000% Increase in Revenues

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has released its  unaudited financial results for the quarter ended Sept. 30, 2021; all numbers are in Canadian dollars. Among the highlights include a revenue growth figure of $1.1 million, which represents more than a 1,000% increase over the $94,000 reported in the same quarter last year. In addition, the company noted gross profit of $356,168 during Q3 2021, compared to a loss of $40,280 for Q3 2020. BevCanna closed the quarter with cash reserves of $655,563. Business highlights include a…

Continue Reading

TuesdayNov 30, 2021 11:52 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Strategy Toward Potential Therapeutics for Diseases with High Unmet Needs

InMed Pharmaceuticals (NASDAQ: INM) recently filed a Patent Cooperation Treaty (“PCT”) application, which specifies a rare cannabinoid (new to InMed’s portfolio) that may inhibit or slow the progression of neurogenerative diseases – such as Alzheimer’s, Parkinson’s, Huntington’s and others – by providing protection in a population of affected neurons. Furthermore, the application demonstrates the cannabinoid can also be used to promote neurite outgrowth, signifying the potential to enhance neuronal function. According to InMed’s Senior VP Pre-Clinical Research & Development Dr. Eric Hsu, who is quoted in a recent article, “This PCT patent application advances our strategy directed towards researching and…

Continue Reading

TuesdayNov 30, 2021 10:30 am

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Q3 2021 Results, Including 93% YOY Revenue Increase

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced 2021 third quarter financial results. Among the highlights, the company reported a 93% increase in third quarter year-over-year revenue. “In the third quarter, we made excellent progress in laying additional building blocks in our core operating states of Florida, Michigan and California to become more vertically integrated where it will be most profitable,” said Brad Rogers, RWB chairman and CEO. “This will help drive increased revenue and margins for the company. Simultaneously, we are gaining significant market share with our…

Continue Reading

MondayNov 29, 2021 12:17 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Refiling of Amended, Restated MD&A and Financial Statements

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has amended, restated and refiled information covering the three and six months ended June 30, 2021. Information refiled includes RYAH’s management discussion and analysis (“MD&A”) and condensed, consolidated interim financial statements for the six months ended June 30, 2021. The MD&A material includes information regarding the company's operations, business objectives, and relationships with third parties as well as marketing expenditures incurred during the three- and six-month period ended June 30, 2021. The material…

Continue Reading

MondayNov 29, 2021 10:40 am

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Report on 2021 Shareholder General and Special Meeting

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, announced that at its annual general and special meeting of shareholders (“AGM”) all agenda items were approved. The meeting was held on Nov. 24, 2021. Included in the agenda items were the election of directors and the appointment of an auditor. According to the company, four individuals were elected to the board, including Marcello Leone, John Campbell, Martino Ciambrelli and Phil Fontaine. In addition, Dale Matheson Carr-Hilton Labonte LLP (“DMCL”) was reappointed as the company auditor for the next year. To view…

Continue Reading

WednesdayNov 24, 2021 2:31 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Makes Expansion of Platinum Vape Brand Top Priority

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently announced the completion of an agreement for the transition of the management at Platinum Vape LLC (“PV”), having settled all additional PV acquisition price considerations. “RWB estimates that production of PV vape carts will increase to over 450,000 in November, a projection that has made expansion of the PV brand a top priority. Michigan and California are proving to be the two vital promising markets pushing for this growth, prompting focus on PV and streamlining its operations,” reads a recent article. The management transition saw the addition of Shea Alderete…

Continue Reading

WednesdayNov 24, 2021 1:25 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates 10-20X Faster Nicotine Delivery in Recent Study

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently conducted a study on canines in collaboration with an independent testing laboratory. The analysis evaluated nicotine benzoate and polacrilex plasma levels in 40 anesthetized male beagle dogs comparing Lexaria’s recently developed, advanced DehydraTECH 2.0 nicotine formulation to concentration-matched controls. The dogs’ blood samples were taken every few minutes over the course of two hours. “The results from the study showed that the generic nicotine benzoate pouch required about 45 minutes to reach its peak delivery rate. In comparison, the DehydraTECH-nicotine benzoate pouch reached peak delivery rates at both eight minutes and again at 30…

Continue Reading